Request for regulatory guidance for cancer cachexia intervention trials
نویسندگان
چکیده
Clinical and Surgical Sciences, School of Clinical Sciences and Community Health, Royal Infirmary, University of Edinburgh, Edinburgh, UK; Biochemistry and Molecular Biology of Cancer, Faculty of Biology, University of Barcelona, Barcelona, Spain; Department of Oncology, University of Alberta, Edmonton, Alberta , Canada; Department of Geriatrics, Neurosciences, and Orthopedics, Catholic University of the Sacred Heart, Roma, Italy; Monash University, Australia; University of Warwick, UK; Duke Cancer Institute, Durham, NC , USA; Center for Translational Research in Aging and Longevity, Department of Health and Kinesiology, Texas A&M University, College Station, TX 77843, USA; Center for Stroke Research CSB, Charité – Universitätsmedizin Berlin, Germany; KineMed, Inc., Emeryville, CA 94608, USA; Division of Geriatrics, Duke Medical Center, Durham, NC 27710, USA; Intramural Research Program, National Institute on Aging, NIH, Baltimore, MD 20892, USA; Division of Endocrinology, Diabetes and Metabolism, Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey VA Medical Center, and Baylor College of Medicine, Houston, TX 77030, USA; Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY 10461, USA; Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA; Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, CA 92868, USA; Department of Cardiology and Department of Research and Education, General Hospital Celje, Celje, Slovenia; Divisions of Geriatric Medicine and Endocrinology, Saint Louis University School of Medicine, St Louis, MO 63103, USA; Department of Clinical Medicine, Sapienza University, Rome, Italy; NIHR Respiratory Biomedical Research Unit at the Royal Brompton and NHS Foundation Trust and Imperial College, London, UK; Department of Medical Sciences, IRCCS San Raffaele Roma. Nutramed Consortium, Italy; NUTRIM School of Nutrition and Translational Research in Metabolism, Department of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands; Oncological Palliative Medicine, Clinic Oncology/Hematology, Department Internal Medicine and Palliative Centre, Cantonal Hospital St.Gallen, Switzerland; Department of Geriatrics, CHU Toulouse, Toulouse, France; Innovative Clinical Trials, Department of Cardiology & Pneumology, University Medical Center Göttingen (UMG), Göttingen, Germany
منابع مشابه
The effect of a period of resistance training on the muscle proteasome activity and autophgy flux in mice with cancer induce cachexia
Introdution: Muscle weakness that is caused by cancer called Cachexia. One of the causes of the formation of the cachexia is the change in protein degradation, and the ubiquitous protease and Autophagy Lysosomes system is the most important protein breakdown system. Resistance training has been one the best stimulator of increasing muscular mass. Therefore, the purpose of this study was to inve...
متن کاملExercise for cancer cachexia in adults: Executive summary of a Cochrane Collaboration systematic review
BACKGROUND Cancer cachexia is a complex syndrome characterized by an ongoing loss of skeletal muscle mass and progressive functional impairment. A proactive management approach is recommended, including physical exercise to maintain function via modulation of muscle metabolism, insulin sensitivity and levels of inflammation. The review aimed to determine the safety, acceptability and effectiven...
متن کاملA randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer
BACKGROUND Cancer cachexia is a syndrome of weight loss (including muscle and fat), anorexia, and decreased physical function. It has been suggested that the optimal treatment for cachexia should be a multimodal intervention. The primary aim of this study was to examine the feasibility and safety of a multimodal intervention (n-3 polyunsaturated fatty acid nutritional supplements, exercise, and...
متن کاملThe Role of microRNA in Cancer Cachexia and Muscle Wasting: A Review Article
Almost half of cancer patients experience cachexia syndrome. Cachexic patients are at risk of increased side effects of chemotherapy, reduced tolerance to chemotherapy drugs, longer duration of treatment period, and decreased quality of life. Cancer cachexia is a multifactorial syndrome. Micro ribonucleic acid (miRNA), a “non-coding RNA”, is considered to be a risk factor of cachexia and muscle...
متن کاملConference on ‘Nutrition and age-related muscle loss, sarcopenia and cachexia’ Symposium 3: Nutrition for prevention and interventions for sarcopenia and cachexia The effectiveness of nutritional interventions in malnutrition and cachexia
Cancer is a common diagnosis and leading cause of death worldwide. Amounts of weight loss vary but it is associated with considerable morbidity, poorer quality of life and reduced survival. Nutritional intervention has the potential to maximise response to treatment and improve functioning and quality of life. The aim of this paper was to review the evidence for oral nutritional interventions i...
متن کامل